Financials / Shell CompaniesUpdated 2026-05-10 22:07 UTC

DMAA stock hub

Drugs Made In America Acquisition Corp. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

DMAAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

357.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

DMAA

In the news

Latest news · DMAA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 8.8P50 10.4P75 13.1

Trailing P/E56.5

P25 10.9P50 14.7P75 36.2

ROEn/a

P25 4.9P50 10.4P75 15

ROICn/a

P25 -1.3P50 6.6P75 12.7

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All DMAA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

128

Groups with data

Currency

USD

Showing 128 of 128 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002028614
Company name	Drugs Made In America Acquisition Corp.
Country	United States
Country code	US
Enterprise value	$357.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Shell Companies
IPO Date	2025-01-28
Isin	KYG2847J1040
Last refreshed	2026-05-10
Market cap	$357.4M
Market cap category	Small-Cap
Price	$10.6
Price currency	USD
Sector	Financials
Sic	6770
Symbol	DMAA
Website	https://dmaacorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.66%
EV Earnings	60.16x
P/E ratio	56.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$5.9M
ROA	-1.46
ROCE	-1.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	4.95%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$239.9M
Cash	$6,137
Current Assets	$12,191
Current Liabilities	$376,172
Equity	$-7.3M
Liabilities	$247.2M
Long Term Assets	$239.9M
Long Term Liabilities	$246.8M
Net Cash	$6,137
Net Cash By Market Cap	$0
Tangible Book Value	$-7.3M
Tangible Book Value Per Share	$-0.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.03
Net Working Capital	$-370,118
Quick ratio	0.02
Working Capital	$-363,981

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	4.95%
200-day SMA	10.35
50-day SMA	10.51
50-day SMA vs 200-day SMA	50over200
All Time High	10.6
All Time High Change	-0.01%
All Time High Date	2026-05-06
All Time Low	9.95
All Time Low Change	6.53%
All Time Low Date	2025-02-25
ATR	0.02
Beta1y	-0.01
Beta2y	0
Ch YTD	2.18
High	10.6
High52	10.6
High52 Date	2026-05-06
High52ch	-0.01%
Low	10.57
Low52	10.09
Low52 Date	2025-05-12
Low52ch	5.06%
Ma50ch	0.9%
Price vs 200-day SMA	2.38%
RSI	69.5
RSI Monthly	97.8
RSI Weekly	93.71
Sharpe ratio	0.66x
Sortino ratio	3.56
Tr YTD	2.18
Tr1m	0.86%
Tr1w	0.28%
Tr3m	1.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-2.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,311,935%
Float Percent	81%
Net Borrowing	-900,000
Shares Insiders	1.19%
Shares Institutions	62.74%
Shares Out	33,717,143
Shares Qo Q	2%
Short Float	5.37%
Short Ratio	7.55
Short Shares	4.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	269,568.8x
Bv Per Share	-0.22
Ch1m	0.86
Ch1w	0.28
Ch1y	4.95
Ch3m	1.53
Ch6m	2.78
Change	0%
Change From Open	0.28
Close	10.6
Days Gap	-0.28
Dollar Volume	490,886
EBIT	$-2.8M
EPS	$0.19
F Score	1
Financing CF	231,693,973
Fiscal Year End	December
Founded	2,024
Investing CF	-231,150,000
Ipr	6
Is Primary Listing	1
Is Spac	Yes
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-15
Ma150	10.39
Ma150ch	2%
Ma20	10.55
Ma20ch	0.45%
Net CF	4,786
Open	10.57
Optionable	No
Position In Range	100
Post Close	10.6
Postmarket Change Percent	-0.28
Postmarket Price	$10.57
Price Date	2026-05-08
Relative Volume	0.17x
Tr6m	2.79%
Us State	Florida
Volume	46,310

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does DMAA pay a dividend?

Capital-return profile for this ticker.

Performance

DMAA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns DMAA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+62.7%

Float: +81.0% of shares outstanding

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

DMAA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.5

Neutral momentum band

Price vs 200-day MA

+2.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Peers

DMAA vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AXP	American Express Company	215.6B	19.7x	3.1x	11.5%	+15.5%	+15.6%	Reduzieren
BAC	Bank of America Corporation	364.1B	12.7x	3.3x	—	+6.3%	+28.2%	Reduzieren
BK	The Bank of New York Mellon Corporation	89.6B	16.2x	4.3x	—	+6.0%	+58.4%	Reduzieren

Questions

About DMAA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DMAA stock rating?

Drugs Made In America Acquisition Corp. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DMAA analysis?

The full report lives at /stocks/DMAA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DMAA?

The latest report frames DMAA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DMAA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.